Computational neural network analysis of the affinity of lobeline and tetrabenazine analogs for the vesicular monoamine transporter-2

被引:23
|
作者
Zheng, Fang [1 ]
Zheng, Guangrong [1 ]
Deaciuc, A. Gabriela [1 ]
Zhan, Chang-Guo [1 ]
Dwoskin, Linda P. [1 ]
Crooks, Peter A. [1 ]
机构
[1] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA
关键词
lobeline analog; QSAR; partial least squares; artificial neural network; VMAT2;
D O I
10.1016/j.bmc.2007.02.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Back-propagation artificial neural networks (ANNs) were trained on a dataset of 104 VMAT2 ligands with experimentally measured log(l/K-i) values. A set of related descriptors, including topological, geometrical, GETAWAY, aromaticity, and WHIM descriptors, was selected to build nonlinear quantitative structure-activity relationships. A partial least squares (PLS) regression model was also developed for comparison. The nonlinearity of the relationship between molecular descriptors and VMAT2 ligand activity was demonstrated. The obtained neural network model outperformed the PLS model in both the fitting and predictive ability. ANN analysis indicated that the computed activities were in excellent agreement with the experimentally observed values (r(2) = 0.91, rmsd = 0.225; predictive q(2) = 0.82, loormsd = 0.316). The generated models were further tested by use of an external prediction set of 15 molecules. The nonlinear ANN model has r(2) = 0.93 and root-mean-square errors of 0.282 compared with the experimentally measured activity of the test set. The stability test of the model with regard to data division was found to be positive, indicating that the generated model is predictive. The modeling study also reflected the important role of atomic distribution in the molecules, size, and steric structure of the molecules when they interact with the target, VMAT2. The developed models are expected to be useful in the rational design of new chemical entities as ligands of VMAT2 and for directing synthesis of new molecules in the future. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2975 / 2992
页数:18
相关论文
共 50 条
  • [41] Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release
    Chu, Pei-Wen
    Hadlock, Gregory C.
    Vieira-Brock, Paula
    Stout, Kristen
    Hanson, Glen R.
    Fleckenstein, Annette E.
    JOURNAL OF NEUROCHEMISTRY, 2010, 115 (02) : 325 - 332
  • [42] Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications
    Fleckenstein, Annette E.
    Volz, Trent J.
    Hanson, Glen R.
    NEUROPHARMACOLOGY, 2009, 56 : 133 - 138
  • [43] Synthesis and biological evaluation of tetrabenazine derivatives for brain vesicular monoamine transporter VMAT2 imaging
    Papin, Caroline
    Alagille, David
    Lee, Sharon
    Barret, Olivier
    Baldwin, Ronald M.
    Tamagnan, Gilles
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [44] Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex
    Kitanaka, Nobue
    Kitanaka, Junichi
    Hall, F. Scott
    Kandori, Takashi
    Murakami, Ayaka
    Muratani, Kazuki
    Nakano, Tae
    Uhl, George R.
    Takemura, Motohiko
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2018, 172 : 9 - 16
  • [45] HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum
    Theodore, Shaji
    Cass, Wayne A.
    Dwoskin, Linda P.
    Maragos, William F.
    SYNAPSE, 2012, 66 (08) : 755 - 757
  • [46] A di-leucine-like sequence mediates endocytosis of the vesicular monoamine transporter-2 (VMAT2).
    Tan, PK
    Waites, C
    Liu, Y
    Edwards, RH
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 1747 - 1747
  • [47] In vitro assessment of dopamine uptake and methamphetamine-induced dopamine efflux at the vesicular monoamine transporter-2
    Volz, TJ
    Hanson, GR
    Fleckenstein, AE
    FASEB JOURNAL, 2006, 20 (04): : A684 - A684
  • [48] GZ-793A, a lobelane analog, interacts with the vesicular monoamine transporter-2 to inhibit the effect of methamphetamine
    Horton, David B.
    Nickell, Justin R.
    Zheng, Guangrong
    Crooks, Peter A.
    Dwoskin, Linda P.
    JOURNAL OF NEUROCHEMISTRY, 2013, 127 (02) : 177 - 186
  • [49] Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles
    Volz, Trent J.
    Farnsworth, Sarah J.
    King, Jill L.
    Riddle, Evan L.
    Hanson, Glen R.
    Fleckenstein, Annette E.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (02): : 738 - 745
  • [50] MELATONIN ATTENUATES AMPHETAMINE-INDUCED DECREASE IN VESICULAR MONOAMINE TRANSPORTER-2 IN POSTNATAL RAT STRIATUM
    Mukda, S.
    Govitrapong, P.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 39 - 39